These results indicate that both CBD and HU308 significantly reduce the levels of pro-inflammatory cytokines IL-6, IL-1β, MCP-1, and TNF-α in DSS-induced colitis, thereby demonstrating their potential as effective anti-inflammatory agents in this model. The gene discussed is CCL2; the disease is colitis.